The Ratio of Femoral Vein Diameter to Femoral Artery Diameter to Predict Fluid Responsiveness in Children

Sponsor
Tanta University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05992246
Collaborator
(none)
85
1
11.4
7.5

Study Details

Study Description

Brief Summary

The hypothesis of the study will be that the ratio of femoral vein diameter to femoral artery diameter will have correlation with fluid status in pediatrics.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Ratio of Femoral Vein Diameter to Femoral Artery Diameter

Detailed Description

Proper administration of intravenous fluids is an important part of treating circulatory failure in children and affects the clinical outcome of the management of the child's emergency. Giving a small amount of fluid will cause tissue hypoperfusion and worsen organ dysfunction and cause ischemia. On the other hand, excess fluid interferes with oxygen delivary, exacerbates treatment outcomes, increases complications, and extends both the length of the stay in intensive care and mortality. The use of bedside ultrasound by pediatric intensive care physicians has become so critical in recent years that it is now a component of physical examination in ICUs

Study Design

Study Type:
Observational
Anticipated Enrollment :
85 participants
Observational Model:
Case-Crossover
Time Perspective:
Prospective
Official Title:
The Validity of the Ratio of Femoral Vein Diameter to Femoral Artery Diameter to Predict Fluid Responsiveness in Children
Anticipated Study Start Date :
Aug 20, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Outcome Measures

Primary Outcome Measures

  1. Measurement of changes in the ratio of femoral vein diameter to femoral artery diameter [immediate preoperative period before the induction of general anesthesia]

    Measurement of changes in the ratio of femoral vein diameter to femoral artery diameter before and after fluid challenge which will be defined as infusion of ringer lactate 10 ml/kg body weight over 20 min.

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • children with American society of anaesthesiologist physical status 1-2

  • 2-10 years of age

  • scheduled for elective surgery

  • signs of moderate to severe dehydration

Exclusion Criteria:
  • Patients with mild dehydration.

  • Patients with history of significant comorbid conditions or previous laparotomy.

  • Congenital heart disease.

  • Heart failure.

  • Disorder of venous return like arteriovenous fistula, DVT or Varicose veins.

  • Increase intra-abdominal pressure.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of medicine, Tanta university Tanta El Gharbyia Egypt 31111

Sponsors and Collaborators

  • Tanta University

Investigators

  • Study Director: sameh Fathi, MD, tanta university, faculty of medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
tarek abdel hay mostafa, principle investigator, Tanta University
ClinicalTrials.gov Identifier:
NCT05992246
Other Study ID Numbers:
  • Pediatric Fluid Responsiveness
First Posted:
Aug 15, 2023
Last Update Posted:
Aug 15, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 15, 2023